| 0 (0%) | 12-05 10:02 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.89 | 1-year : | 26.73 |
| Resists | First : | 19.6 | Second : | 22.89 |
| Pivot price | 18.95  |
|||
| Supports | First : | 18.16 |
Second : | 17.27 |
| MAs | MA(5) : | 19.18  |
MA(20) : | 18.94 |
| MA(100) : | 18.56 |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 59.3 |
D(3) : | 69.2 |
| RSI | RSI(14): 52.8 |
|||
| 52-week | High : | 19.96 | Low : | 15.6 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SBRA ] has closed above bottom band by 49.6%. Bollinger Bands are 7.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 19.31 - 19.43 | 19.43 - 19.51 |
| Low: | 18.72 - 18.87 | 18.87 - 18.98 |
| Close: | 18.85 - 19.07 | 19.07 - 19.23 |
Wed, 03 Dec 2025
Sabra Healthcare REIT, Inc. $SBRA Shares Purchased by Schroder Investment Management Group - MarketBeat
Tue, 02 Dec 2025
How SBRA stock compares to growth peers - 2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - Newser
Mon, 01 Dec 2025
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
Mon, 01 Dec 2025
Franklin Resources Inc. Increases Stake in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sun, 30 Nov 2025
(SBRA) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Sat, 29 Nov 2025
Truist Financial Reaffirms Their Hold Rating on Sabra Healthcare REIT (SBRA) - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 249 (M) |
| Shares Float | 245 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 98.7 (%) |
| Shares Short | 19,470 (K) |
| Shares Short P.Month | 18,950 (K) |
| EPS | 0.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.32 |
| Profit Margin | 23.4 % |
| Operating Margin | 31 % |
| Return on Assets (ttm) | 3.2 % |
| Return on Equity (ttm) | 6.2 % |
| Qtrly Rev. Growth | 7.3 % |
| Gross Profit (p.s.) | 1.99 |
| Sales Per Share | 2.99 |
| EBITDA (p.s.) | 1.82 |
| Qtrly Earnings Growth | -29.3 % |
| Operating Cash Flow | 341 (M) |
| Levered Free Cash Flow | 197 (M) |
| PE Ratio | 25.95 |
| PEG Ratio | 0 |
| Price to Book value | 1.67 |
| Price to Sales | 6.32 |
| Price to Cash Flow | 13.84 |
| Dividend | 0.3 |
| Forward Dividend | 0 |
| Dividend Yield | 1.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|